| __timestamp | Dr. Reddy's Laboratories Limited | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 9335772 |
| Thursday, January 1, 2015 | 62786000000 | 999000 |
| Friday, January 1, 2016 | 62427000000 | 978000 |
| Sunday, January 1, 2017 | 62453000000 | 952000 |
| Monday, January 1, 2018 | 65724000000 | 956000 |
| Tuesday, January 1, 2019 | 70421000000 | 8122999 |
| Wednesday, January 1, 2020 | 80591000000 | 8712000 |
| Friday, January 1, 2021 | 86645000000 | 13980000 |
| Saturday, January 1, 2022 | 100551000000 | 21135000 |
| Sunday, January 1, 2023 | 42907000000 | 10755000 |
| Monday, January 1, 2024 | 115557000000 |
Unlocking the unknown
In the ever-evolving landscape of the pharmaceutical and biotech industries, understanding cost structures is crucial. Dr. Reddy's Laboratories Limited, a global pharmaceutical giant, and Iovance Biotherapeutics, Inc., a pioneering biotech firm, present a fascinating contrast in their cost of revenue over the past decade.
From 2014 to 2023, Dr. Reddy's Laboratories consistently reported a cost of revenue that dwarfed Iovance's, with figures often exceeding 10 billion USD. In contrast, Iovance's cost of revenue remained below 20 million USD, highlighting the stark difference in scale and operational scope. Notably, Dr. Reddy's saw a significant dip in 2023, with costs dropping to approximately 4.3 billion USD, while Iovance's costs remained relatively stable.
This comparison underscores the diverse financial landscapes within the pharmaceutical and biotech sectors, offering insights into their operational efficiencies and market strategies.
Cost of Revenue: Key Insights for Eli Lilly and Company and Iovance Biotherapeutics, Inc.
Novo Nordisk A/S vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Gilead Sciences, Inc. and Iovance Biotherapeutics, Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost of Revenue Comparison: Zoetis Inc. vs Iovance Biotherapeutics, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost of Revenue Trends: Jazz Pharmaceuticals plc vs Iovance Biotherapeutics, Inc.
Comparing Cost of Revenue Efficiency: Grifols, S.A. vs Iovance Biotherapeutics, Inc.
Corcept Therapeutics Incorporated vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: HUTCHMED (China) Limited vs Iovance Biotherapeutics, Inc.